Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone

Psychosomatic Medicine

Volumn 60, Issue 1, 1998, Pages 89-91

  Khouzam, Hani Raoul ^a,b,c   Monteiro, Alexandrino J ^a   Gerken, Madeline E ^a,b,c  

^a Manchester VA Medical Center   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chemotherapy; Depression; Emesis; Nefazodone; Small cell lung cancer

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; NEFAZODONE; PROCHLORPERAZINE; VINCRISTINE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DEPRESSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOTHERAPY; VOMITING;

EID: 0031939780     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199801000-00018     Document Type: Article

References (32)

1. Perez EA: Overview: Oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting. Semin Oncol 22(Suppl 10):1-2, 1995
2. Jenns K: Importance of nausea. Cancer Nurs 17:488-493, 1994
3. Grunberg SM, Hesketh PJ: Control of chemotherapy-induced emesis. N Engl J Med 329:1790-1796, 1993
4. Ettinger DS: Preventing chemotherapy-induced nausea and vomiting: An update and a review of emesis. Semin Oncol 22(Suppl 10):6-18, 1995
5. Morrow GR, Lindke J, Black PM: Predicting development of anticipatory nausea in cancer patients: Prospective examination of eight clinical characteristics. J Pain Symptom Manage 6:215-223, 1991
6. Miner WD, Sanger GJ: Inhibition of Cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497-499, 1986
7. Bergeron R, Blier P: Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors. Am J Psychiatry 151:1084-1086, 1994
8. Folstein, MF, Folstein SE, McHugh PR: "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975
9. Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17:37-49, 1983
10. Khouzam HR: Two mnemonics to aid in the differential diagnosis of dementia. Consultant 36:2266-2267, 1996
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder, 4th Edition. DSM-IV. Washington, DC, American Psychiatric Association, 1994, 321-327
12. Sheperd FA, Amdcmichael E, Evans WK, et al: Treatment of small cell cancer in the elderly. J Am Geriatr Soc 42:64-70, 1994
13. Ingle RJ, Burish TG, Wallace KA: Conditionability of cancer chemotherapy patients. Oncol Nurs Forum 11:97-102, 1984
14. Richardson JL, Marks G, Levine A: The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 6:1746-1752, 1988
15. Stafanini E, Clement-Cormier Y: Detection of dopamine receptors in the area postrema. Eur J Pharmacol 74:257-260, 1981
16. Wyant GM: A comparative study of eleven anti-emetic drugs in dogs. Can Anaesth Soc J 9:399-407, 1962
17. Grossman B, Lessen LS, Cohen P: Droperidol prevents nausea and vomiting from cisplatinum. N Engl J Med 301:47, 1979
18. Herman TS, Einhorn LH, Jones SE: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 300:1295-1297, 1979
19. Bakowski MT: Advances in anti-emetic therapy. Cancer Treat Rev 11:237-256
20. Hesketh PJ, Gandara DR: Serotonin antagonists: A new class of antiemetic agents. J Natl Cancer Inst 83:613-620, 1991
21. Katz IR: On the inseparability of mental and physical health in aged persons: Lessons from depression and medical comorbidity: Am J Geriatr Psychiatry 4:1-16, 1996
22. Caine ED, Lyness JM, King DA: Reconsidering depression in the elderly. Am J Geriatr Psychiatry 1:4-20, 1993
23. Lesko LM, Massie MJ, Holland J: Oncology. In Stoudemire A, Fogel BS (eds), Psychiatric Care of the Medical Patient. New York, Oxford University Press, Inc, 1993, 565-590
24. Rodin G, Voshart K: Depression in the medically ill: An overview. Am J Psychiatry 143:695-705, 1986
25. McCue RE, Aronowitz J: Accelerated antidepressant response in geriatric inpatients. Am J Geriatr Psychiatry 2:244-246, 1994
26. Davis CL, Hardy JR: Palliative care. Br Med J 308:1359-1362, 1994
27. Vigano A, Watanabe S, Bruera E: Palliative medicine. Problem areas in pain and symptom management. Cancer Surv 21:99-115, 1994
28. Nelson KA, Walsh D, Sheehan FA: The cancer anorexia-cachexia syndrome. J Clin Oncol 12:213-225, 1994
29. Eison AS, Eison MS, Torrente JR, et al: Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 26:311-315, 1990
30. Fontaine R, Ontiveros A, Elie R, et al: A double-blind comparison of nefazodone, imipramine and placebo in major depression. J Clin Psychiatry 55:234-241, 1994
31. Fontaine R: Novel serotonergic mechanisms and clinical experience with nefazodone. Clin Neuropharmacol 51 (Suppl 90):13-17, 1993
32. Leonard BD: Subtypes of serotonin receptors: Biochemical changes and pharmacological consequences. Int Clin Psychopharmacol 7:13-21, 1992